Latest Articles
Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress - Morningstar
Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress Morningstar
Published: Oct. 29, 2025, 5:27 p.m.
T cells leads to functional abnormalities that promote endometriosis progression - BMC Medicine
T cells leads to functional abnormalities that promote endometriosis progression BMC Medicine
Published: Oct. 27, 2025, 1 p.m.
Spotlight on Women’s Reproductive Health - Inside Precision Medicine
Spotlight on Women’s Reproductive Health Inside Precision Medicine
Published: Oct. 23, 2025, 10:12 p.m.
Circulating biomarkers of infection and endometrial cancer risk - springermedicine.com
Circulating biomarkers of infection and endometrial cancer risk springermedicine.com
Published: Oct. 16, 2025, 2:26 a.m.
Sildenafil in Reproductive Medicine: Promise, Paradox, and the Pursuit of a Receptive Endometrium - viagra8ordernow.com
Sildenafil in Reproductive Medicine: Promise, Paradox, and the Pursuit of a Receptive Endometrium viagra8ordernow.com
Published: Oct. 15, 2025, 9:23 p.m.
SMC Issues Advice on 7 Medicines in Latest Meeting - NAVLIN DAILY
SMC Issues Advice on 7 Medicines in Latest Meeting NAVLIN DAILY
Published: Oct. 14, 2025, 12:08 p.m.
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Oct. 8, 2025, 7:30 p.m.
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III - insights.citeline.com
Hope Medicine Ready To Bring Potential First-in-Class Endometriosis Treatment Into Phase III insights.citeline.com
Published: Oct. 8, 2025, 2:15 p.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - Vulcan Post
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment Vulcan Post
Published: Oct. 8, 2025, 7:33 a.m.
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment - The Malaysian Reserve
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment The Malaysian Reserve
Published: Oct. 8, 2025, 2:14 a.m.
Link copied to clipboard!